UOB Kay Hian

Stay informed with us

By subscribing, you agree to receive research insights and marketing communications from us. You may unsubscribe at any time. See our Privacy Policy for details.

CSPC Innovation Pharmaceutical Co (300765 CH): 1H26: Achieves Breakeven; Smooth BD And R&D Progress Bolster Long-Term Prospects | Research | UOB Kay Hian Hong Kong